Development of a virus-mimicking nanocarrier for drug delivery systems: The bio-nanocapsule
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 95, 77-89
Abstract
No abstract availableKeywords
Funding Information
- The Naito Foundation
- The Okawa Foundation
- KAKENH
- Scientific Research (25242043)
- JSPS Fellows (25003835)
- Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare
This publication has 101 references indexed in Scilit:
- Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomesJournal of Nanobiotechnology, 2013
- Nano-visualization of oriented-immobilized IgGs on immunosensors by high-speed atomic force microscopyScientific Reports, 2012
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- A Function Essential to Viral Entry Underlies the Hepatitis B Virus “a” DeterminantJournal of Virology, 2009
- Biological Gene Delivery Vehicles: Beyond Viral VectorsMolecular Therapy, 2009
- Viral membrane fusionNature Structural & Molecular Biology, 2008
- Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycansHepatology, 2007
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007
- Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNAProceedings of the National Academy of Sciences, 2007
- Octaarginine-modified multifunctional envelope-type nanoparticles for gene deliveryGene Therapy, 2007